Skip to product information
1 of 5

OFLOWIN Ophthalmic Solution 5ml

OFLOWIN Ophthalmic Solution 5ml

Regular price Rs. 58.12
Regular price Rs. 58.12 Sale price Rs. 58.12
Sale Sold out
Tax included. Shipping calculated at checkout.
OFLOWIN 0.3% OPHTHALMIC SOLUTION contains Ofloxacin, which belongs to the group of medicines called Antibiotics. It is used to manage...
Currently there are peoples are currently looking at this product

Shipping & Returns

Enjoy fast and reliable delivery with orders typically arriving within 3–7 business days.
Returns are accepted within 7 days of delivery for eligible products that are unused and in their original condition.

Share Product

SKU:1052358

Categories: Eye Infections , Medicine

Tags: discount_eligible , eye_infections , jiomart

View full details

OFLOWIN 0.3% OPHTHALMIC SOLUTION contains Ofloxacin, which belongs to the group of medicines called Antibiotics. It is used to manage external eye infections like certain types of conjunctivitis. It can also be used to manage ulcers of the cornea. Conjunctivitis is also known as pink eye due to its major complaint of eye redness, with or without pain, itching and discharge.

A corneal ulcer is an open lesion on the cornea (transparent layer of the eye), characterized by eye redness, severe pain, tearing, soreness, pus or other discharge, a feeling of having something in your eye, blurred eyesight, sensitivity to light or swelling of the eyelids.

Avoid exposure to the sun while using OFLOWIN 0.3% OPHTHALMIC SOLUTION. Before using OFLOWIN 0.3% OPHTHALMIC SOLUTION, inform your doctor if you wear contact lenses, have defects of the eye surface or have any heart problems. OFLOWIN 0.3% OPHTHALMIC SOLUTION should be used with caution in pregnant and breastfeeding women only if advised by your doctor. OFLOWIN 0.3% OPHTHALMIC SOLUTION should be used with caution in children.

The most common side effects of using OFLOWIN 0.3% OPHTHALMIC SOLUTION are eye irritation, ocular burning or discomfort. Contact your doctor if any of the symptoms worsen.

No content available